100,000 cells seeded per well. A culture consisting of only LPCs served as a
control. These cultures were maintained in DMEM/F12 supplemented with 30 ng/ml
insulin growth factor-II (IGF-II), 50 ng/ml EGF, 10 μg/ml insulin, 100 U/ml
penicillin and streptomycin, and 10% FBS. For hAEC-CM treatment, LPCs were
seeded in tissue culture plates (six, 24, and 96 well) at a density of 8.3 ×
103 cells/cm2 in Roswell Park Memorial Institute
Medium (RPMI) 1640 medium GlutaMAX (Gibco) with 10% FBS, 30 ng/ml IGF-II (Sino
Biological Inc., Beijing, China), 50 ng/ml EGF, and 10 μg/ml insulin (Sigma
Aldrich). Medium was changed 3 days later to control medium, hAEC-CM, or control
medium consisted of RPMI GlutaMax, 50% Dulbecco’s phosphate-buffered saline
(Gibco) containing 5% FBS, 30 ng/ml IGF-II, 50 ng/ml EGF, 10 μg/ml insulin, and
100 U/ml penicillin and streptomycin (Gibco); hAEC-CM was RPMI GlutaMax, 50%
hAEC-CM, 5% FBS, 30 ng/ml IGF-II, 50 ng/ml EGF, 10 μg/ml insulin, and 100U/ml
penicillin and streptomycin. Cultures were maintained at 37°C in 95% humidity
and 5% carbon dioxide with the medium changed every 3 days.